Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1994
Frequency of electroconvulsive therapy use at a provincial mental hospital: a retrospective studyJ Karagianis
Current Molecular Pharmacology|December 22, 2009
Can increased food intake improve psychosis? A brief review and hypothesisT Treuer, J Karagianis, V P Hoffmann
International Journal of Clinical Practice|October 21, 2009
Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studiesC J Bushe, A J Bradley, S Doshi, et al.
International Journal of Clinical Practice|August 19, 2011
Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational studyA J M Brnabic, K Kelin, H Ascher-Svanum, et al.
Pharmacopsychiatry|May 7, 2010
The number needed to treat for all-cause medication discontinuation in the treatment of schizophrenia: consistency across world geographies and study designsD Novick, H Ascher-Svanum, B Zhu, et al.
International Journal of Clinical Practice|September 18, 2010
An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS studyJ Karagianis, J Landry, V P Hoffmann, et al.
International Journal of Clinical Practice|September 29, 2009
Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patientsJ Karagianis, D Novick, J Pecenak, et al.
Schizophrenia Research|June 19, 2009
A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS StudyJ Karagianis, L Grossman, J Landry, et al.
International Journal of Clinical Practice|June 30, 2009
Intramuscular olanzapine vs. intramuscular short-acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute maniaR Chandrasena, D Dvoráková, S I Lee, et al.
Pageof 1